The Reliability of a Wearable Inertial System in Healthy Adults.

March 13, 2020 updated by: Gokhan Yazici, Gazi University

The Reliability of a Wearable Inertial System (G-walk) on Gait and Jump Assessment in Healthy Adults.

Gait analysis is an effective tool used for a variety of purposes, including assessing neurological diseases, risk of falling, orthopedic disability and progress during rehabilitation.The analysis of gait and jump performance must be applicable in a clinical setting. Thus; it needs to be easy to apply in a variety of life situations.The measurements should be reproducible, stable, accurate, capable of distinguishing between normal and abnormal conditions, and cost-effective. Jump measures can predict injury risks, serve as talent identification, and replicate explosive competitive activities of athletes. Furthermore, the performance in vertical jumping can be associated with neuromuscular fatigue.The purpose of this study was to confirm the test-retest reliability of the G-walk wearable sensor system for gait and jump parameters in healthy adults.

Study Overview

Status

Completed

Conditions

Detailed Description

The G-Walk determines spatiotemporal parameters as well as pelvic rotations during gait and allows objective and precise analysis of movements with its wearable inertial sensor. It also enables 3D kinematic analysis of the pelvis, providing a functional analysis of disorders in gait caused by neuromuscular diseases The device is placed on an elastic belt and worn on the waist of the person being evaluated, with the center of the device at the fifth lumbar vertebrae. To ensure correct placement of the device, the L4-L5 intervertebral space was palpated via the posterior superior iliac spines.

After the accelerometer was placed, the participants were asked to walk calmly at normal speed, on a 10 m track, and to return to the starting position.

The values and gait characteristics of acceleration in the anteroposterior and mediolateral axes were transferred to the computer software program.

The tilt of the pelvis in the sagittal plane in the flexion-extension direction, the oblique displacement in the coronal plane, the angles of the rotation of movement in the transverse plane and the symmetry values of the right and left sides are obtained. While the symmetry index ranges from 0 to 100, a value closer to 100 indicates that the gait is more symmetrical Following gait assessment, Countermovement jump, static squat jump and Countermovement jump with arms thrust was measured using the device.

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06560
        • Gazi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy adults, 18-35 years old who do not have any concominant diseases.

Description

Inclusion Criteria:

  • Accepting to participate in the study,
  • Healthy adults,
  • Being 18-35 years old,

Exclusion Criteria:

  • having any musculoskeletal, neurological or other pathology potentially affecting their gait and jump performance,
  • Refusing to participate in the study,
  • Having limited cooperation which prevents participation in the study,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Health Adults
Forty-nine healthy participants (30 females, 19 males) completed the test-retest protocol with 7 days between tests. Participants were; 23,58±2,65 years of age, 62,9±10,08 kg of weight and 168,76±8,31 cm of height. Participants included in the study did not have any musculoskeletal, neurological or other pathology potentially affecting their gait and jump performance.
The G-Walk is a wireless sensor device which is placed on an elastic belt and worn on the waist of the person being evaluated. The device is placed with the center of the device at the fifth lumbar vertebrae and the patient is completely free to walk, run and jump wearing this device. The gait and jump performance of the participants was assessed with the participants wearing this device two times to investigate the test-retest reliability. The second being 7 days after the first.
Other Names:
  • Gait Analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Analysis
Time Frame: Reliability of the G-Walk in 7 days

Gait parameters will be assessed via the G-Walk on two separate occasions. The G-Walk is a device that is worn on the waist via an elastic belt. The G-Walk is built with a triaxial accelerometer 16 bit/axes with multiple sensitivity, a triaxial magnetometer 13 bit and a triaxial gyroscope 16 bit/axes with multiple sensitivity. This hardware is capable of acquiring and transmitting data to a computer through a Bluetooth connection and at the end of each analysis an automatic report containing the gait assessment results is ready to be analyzed.

Gait symmetry values of the right and left sides are obtained within this report. While the symmetry index ranges from 0 to 100, a value closer to 100 indicates that the gait is more symmetrical.

Reliability of the G-Walk in 7 days
Jump performance
Time Frame: Reliability of the G-Walk in 7 days
The jump tests protocols included; counter movement jump , squat jump and counter movement jump with arms thrust. At the end of the jump tests, all kinematic parameters concerning the evaluated jump were provided by the software. T Each participant performed a session of three trials for each of the assessed jumps. The jump with the maximum height was accepted for analysis.
Reliability of the G-Walk in 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jump height
Time Frame: Reliability of the G-Walk in 7 days
The jump tests protocols included; counter movement jump , squat jump and counter movement jump with arms thrust. At the end of the jump tests, the height of the jump was given in centimeters by the software.
Reliability of the G-Walk in 7 days
Peak speed
Time Frame: Reliability of the G-Walk in 7 days
The jump tests protocols included; counter movement jump , squat jump and counter movement jump with arms thrust. At the end of the jump tests, the peak speed of the jump was given in meters/second by the software.
Reliability of the G-Walk in 7 days
Maximum concentric power
Time Frame: Reliability of the G-Walk in 7 days
The jump tests protocols included; counter movement jump , squat jump and counter movement jump with arms thrust. At the end of the jump tests, the maximum concentric power of the jump was given in Newtons by the software.
Reliability of the G-Walk in 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2019

Primary Completion (Actual)

October 30, 2019

Study Completion (Actual)

February 15, 2020

Study Registration Dates

First Submitted

March 10, 2020

First Submitted That Met QC Criteria

March 13, 2020

First Posted (Actual)

March 17, 2020

Study Record Updates

Last Update Posted (Actual)

March 17, 2020

Last Update Submitted That Met QC Criteria

March 13, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Gazi U

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on The G-Walk sensor system (G-Walk)

Subscribe